Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,105 total articles
The Chefs' Warehouse, Inc., a leading distributor of specialty food products primarily in the United States, announced it will participate in a fireside chat at the upcoming BMO Global Farm to Market Conference, offering investors insights into the company's operations and outlook.
Integer Holdings Corporation announced Q1 2026 results showing a slight sales increase but declines in adjusted operating income and net income compared to the previous year. The company updated its 2026 outlook reflecting headwinds related to new products and noted an ongoing strategic review to maximize shareholder value. Despite near-term challe…
Immutep Limited announced it has received a Nasdaq notice for not meeting the minimum $1.00 bid price requirement for its American Depositary Shares (ADS) over 30 consecutive business days. The company has 180 days to regain compliance, or risk delisting. The company continues to be listed on the Australian Securities Exchange (ASX) without impact.
Immutep Limited announced the discontinuation of its TACTI-004 Phase III trial evaluating eftilagimod alfa in first-line non-small cell lung cancer due to futility findings. The company is conducting a root cause analysis to understand the unexpected poor performance of the combination therapy and assessing implications for the broader eftilagimod …
CytomX Therapeutics, a clinical-stage biopharmaceutical company focused on developing conditionally activated biologics for cancer treatment, will report its Q1 2026 financial results after U.S. market close on May 7, 2026, and host a subsequent webcast and conference call. The company specializes in PROBODY therapeutics, with a pipeline including …
Elicio Therapeutics, a clinical-stage biotech company, will present at the Bank of America Healthcare Conference to showcase its pipeline of off-the-shelf immunotherapies targeting high-prevalence cancers such as mKRAS-positive pancreatic and colorectal cancers. The company focuses on enhancing cancer-specific T cell activation with its Amphiphile …
Integer Holdings Corporation announced that its Board of Directors has launched a strategic review to evaluate a full range of opportunities, including a potential sale, merger, or strategic business combination, aiming to maximize value for shareholders. The Board remains confident in Integer's standalone strategy but is responding to strong inter…
Illinois Tool Works Inc. reported solid first quarter 2026 results with revenue of $4.02 billion representing a 5% increase. Operating margin improved to 25.4%, driving a 12% increase in GAAP EPS to $2.66. The company raised its full-year 2026 GAAP EPS guidance to a range of $11.10 to $11.50, indicating strong confidence in continued growth and mar…
ALX Oncology announced new data from its Phase 1b/2 trial of evorpacept combined with zanidatamab will be presented at the ESMO Breast Cancer 2026 Congress, highlighting biomarker analyses predictive of response in HER2-positive metastatic breast cancer. The company also plans to report Q1 2026 financial results and host a conference call with expe…
GPGI, Inc. announced that it will hold its first quarter 2026 earnings conference call on May 7, 2026, to discuss financial results for the period ending March 31, 2026. The call will include a Q&A session and a prior press release detailing earnings. GPGI is a diversified, multi-industry company operating under a permanent capital base with a focu…
Atlantic International Corp announced its subsidiary Circle8 Netherlands achieved a top-five ranking among Dutch workforce solutions firms and a 15.2% organic growth rate, generating $1.4 billion annual gross revenue. This growth supports Atlantic's ongoing expansion in IT and technology services across Europe, including AI, cybersecurity, and data…
Prestige Consumer Healthcare Inc. plans to release its fiscal 2026 Q4 and full-year earnings results on May 13, 2026, after market close, with a conference call scheduled the following morning. The company markets and sells a diverse portfolio of consumer healthcare products primarily in the U.S., Canada, and Australia.
Solid Biosciences Inc. announced its largest scientific presence at the 29th Annual Meeting of the American Society of Gene & Cell Therapy, with 5 oral presentations and 11 posters showcasing advancements in its gene therapy pipeline targeting neuromuscular and cardiac diseases. The presentations reflect progress in clinical development, delivery t…
Commerce (Nasdaq: CMRC) announced a broad range of product innovations at Commerce Live 2026 aimed at enhancing core platform capabilities, expanding storefront and B2B functionalities, elevating payment solutions, and introducing AI-driven agentic commerce features. The company highlighted improvements such as multi-language support, advanced prom…
OPKO Health’s subsidiary, BioReference Health LLC, announced the launch of BioReference Direct, a new digital platform allowing consumers to order high-quality laboratory tests online without needing an in-office visit. This platform includes tests for general wellness, men’s and women’s health, and an at-home self-collection STI test in collaborat…
First National Corporation (NASDAQ: FXNC), the bank holding company of First Bank, reported net income of $4.9 million and diluted earnings per share of $0.54 for Q1 2026. The company exceeded budgeted metrics despite a challenging start, driven by increased loan production in March and strong deposit growth at an 8.4% annualized rate. Asset qualit…
Banco Santander Chile released its first quarter 2026 financial results, showcasing a solid performance with a 7.0% quarter-over-quarter profit growth and a return on average equity (ROAE) of 23.0%. The bank demonstrated growth in customer base and fees, effective expense management leading to improved efficiency, and maintained strong capital rati…
Rezolve Ai reported an outstanding Q1 2026 revenue of $60 million, exceeding its total 2025 revenue of $46.8 million in just three months. This performance supports its $360 million revenue guidance for 2026 and signals rapid scaling of its AI-driven commerce platform. The company highlighted expanding enterprise adoption, strategic partnerships, a…
GrowGeneration Corp., a leading supplier of specialty products for controlled environment agriculture and commercial cultivation, will release its Q1 2026 financial results on May 12, 2026, accompanied by a live earnings call. The company highlighted its diverse product offerings and proprietary brands, as well as its online and wholesale business …
Nature's Sunshine Products, Inc., a NASDAQ-listed leader in herbal and nutritional supplements, announced the appointment of John Hnanicek as Chief Technology Officer effective May 4, 2026. Hnanicek brings extensive experience in technology leadership and digital transformation from previous roles at Melaleuca and The Vitamin Shoppe, aiming to mode…
Picard Medical, Inc., parent company of SynCardia Systems, highlights Banner Health's global leadership and extensive clinical experience in total artificial heart (TAH) therapy, having performed over 50 SynCardia Total Artificial Heart implants. The partnership underscores advancements in treating end-stage biventricular heart failure patients as …
Lexicon Pharmaceuticals, a biopharmaceutical company focused on pioneering medicines for neuropathic pain, cardiometabolic diseases, and obesity, announced it will report its first quarter 2026 financial results on May 7, 2026, prior to market open. The company will also host a conference call and webcast to discuss the results and provide a busine…
INmune Bio Inc., a clinical-stage biotechnology company focusing on treatments targeting the innate immune system, announced it will release its financial results for Q1 2026 on May 7, 2026, along with a corporate update via conference call and webcast. The company has ongoing clinical programs targeting neuroinflammation related to Alzheimer's Dis…
Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company specializing in genetic medicines, announced it will present new data and progress on several gene therapy programs at key scientific meetings in May and June 2026. The presentations cover treatments for primary ciliary dyskinesia, cystic fibrosis, and advanced non-small…
Retail Rush, an online buy-online pick-up-in-store consumer auction marketplace operated by Liquidity Services, has reached a $4 million annual revenue run rate since its September 2025 launch in Columbus, Ohio. Retail Rush's model of daily online auctions combined with local pickup has attracted a growing base of repeat customers and offers signif…
